Sphera Funds Management Ltd. Astrazeneca PLC Transaction History

Sphera Funds Management Ltd.

$382 Million
Q3 2025

A detailed history of Sphera Funds Management Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 135,060 shares of AZN stock, worth $12.1 Million. This represents 2.71% of its overall portfolio holdings.

Number of Shares

135,060

Previous 135,060 -0.0%

Holding current value

$12.1 Million

Previous $9.44 Million 9.79%

% of portfolio

2.71%

Previous 2.6%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$64.87 - $75.0 $2.59 Million - $3 Million	-40,000 Reduced 22.85%	135,060 $9.44 Million
Q1 2025 May 15, 2025	SELL	$65.37 - $77.96 $3.27 Million - $3.9 Million	-50,000 Reduced 22.22%	175,060 $12.9 Million
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $2.21 Million - $2.79 Million	35,000 Added 18.42%	225,060 $14.7 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $610,300 - $695,699	10,000 Added 5.55%	190,060 $12.9 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $6.5 Million - $7.27 Million	-105,000 Reduced 36.83%	180,060 $12.1 Million

Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $7.26 Million - $8.23 Million	-115,000 Reduced 28.75%	285,060 $19.8 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $26.9 Million - $35 Million	-497,000 Reduced 55.4%	400,060 $27.1 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $5.22 Million - $13.4 Million	98,450 Added 12.33%	897,060 $49.2 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $2.26 Million - $2.72 Million	-38,207 Reduced 4.57%	798,610 $52.8 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $12.2 Million - $14.7 Million	-218,650 Reduced 20.72%	836,817 $55.5 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $12.8 Million - $15.1 Million	-236,200 Reduced 18.29%	1,055,467 $61.5 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $8 Million - $8.75 Million	143,994 Added 12.55%	1,291,667 $77.6 Million
Q2 2021 Aug 17, 2021	BUY	$48.42 - $60.18 $9.06 Million - $11.3 Million	187,200 Added 19.49%	1,147,673 $68.7 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $12.7 Million - $14.7 Million	270,000 Added 39.1%	960,473 $47.8 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $6.28 Million - $7.52 Million	-129,527 Reduced 15.8%	690,473 $34.5 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $3.71 Million - $4.28 Million	-70,000 Reduced 7.87%	820,000 $44.9 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $13.8 Million - $17.7 Million	320,000 Added 56.14%	890,000 $47.1 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $21.5 Million - $29.3 Million	570,000 New	570,000 $25.5 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $30.9 Million - $35 Million	-770,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $2.61 Million - $2.92 Million	70,000 Added 10.0%	770,000 $0
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $6.57 Million - $7.96 Million	185,000 Added 35.92%	700,000 $28.3 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $19 Million - $21.4 Million	515,000 New	515,000 $19.6 Million

Others Institutions Holding AZN

# of Institutions

1,501

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Astrazeneca PLC Transaction History